MMWR Morb Mortal Wkly Rep. 2022 Jun 3;71(22):725-729. doi: 10.15585/mmwr.mm7122a1.
Melatonin is an endogenous neurohormone that regulates the sleep-wake cycle (1). It is used therapeutically for insomnia in adults and for primary sleep disorders in children (2). Melatonin is regulated by the Food and Drug Administration (FDA) as a dietary supplement. Various synthetic melatonin preparations are widely available over the counter (OTC) in the United States with sales increasing from $285 million in 2016 to $821 million in 2020 (3). Children are at increased risk for melatonin exposure because of the supplement's widespread use and growing popularity as a sleep aid. In 2020, melatonin became the most frequently ingested substance among children reported to national poison control centers (4); however, more research is needed to describe the toxicity and outcomes associated with melatonin ingestions in children. This study assessed isolated melatonin ingestions among the pediatric population (defined here as children, adolescents, and young adults aged ≤19 years) during January 1, 2012-December 31, 2021, using the American Association of Poison Control Centers' National Poison Data System (NPDS). During the 10-year study period, 260,435 pediatric melatonin ingestions were reported to NPDS, and the annual number of ingestions increased 530%. In addition, pediatric melatonin ingestions accounted for 4.9% of all pediatric ingestions reported to poison control centers in 2021 compared with 0.6% in 2012. Pediatric hospitalizations and more serious outcomes due to melatonin ingestions increased during the study period, primarily related to an increase in unintentional ingestions among children aged ≤5 years. Five children required mechanical ventilation, and two died. Consumers and health care professionals should be encouraged to report any melatonin product-related adverse events to MedWatch, the FDA's medical product safety reporting program. Public health initiatives should focus on raising awareness of increasing numbers of melatonin ingestions among children and on the development of preventive measures to eliminate this risk.
褪黑素是一种内源性神经激素,可调节睡眠-觉醒周期 (1)。它被用于治疗成年人失眠和儿童原发性睡眠障碍 (2)。褪黑素受美国食品和药物管理局 (FDA) 监管,作为膳食补充剂。各种合成褪黑素制剂在美国广泛的非处方 (OTC) 销售,销售额从 2016 年的 2.85 亿美元增长到 2020 年的 8.21 亿美元 (3)。由于褪黑素作为助眠剂的广泛使用和日益普及,儿童接触褪黑素的风险增加。2020 年,褪黑素成为向国家中毒控制中心报告的儿童中最常摄入的物质 (4);然而,需要更多的研究来描述儿童摄入褪黑素的毒性和结果。本研究使用美国中毒控制中心协会的国家中毒数据系统 (NPDS),评估了 2012 年 1 月 1 日至 2021 年 12 月 31 日期间儿科人群 (定义为年龄≤19 岁的儿童、青少年和年轻人) 中单独摄入褪黑素的情况。在 10 年的研究期间,NPDS 报告了 260435 例儿科褪黑素摄入事件,摄入事件的年度数量增加了 530%。此外,与 2012 年的 0.6%相比,2021 年儿科褪黑素摄入占所有向中毒控制中心报告的儿科摄入事件的 4.9%。在研究期间,由于摄入褪黑素导致的儿科住院和更严重的后果有所增加,主要与 5 岁以下儿童意外摄入有关。有 5 名儿童需要机械通气,有 2 人死亡。应鼓励消费者和医疗保健专业人员向 FDA 的医疗产品安全报告计划 MedWatch 报告任何与褪黑素产品相关的不良事件。公共卫生倡议应重点提高人们对儿童摄入褪黑素数量不断增加的认识,并制定预防措施以消除这种风险。